Arcellx (ACLX) Operating Leases (2022 - 2025)
Arcellx (ACLX) recorded quarterly Operating Leases of $44.3 million in Q4 2025, little changed quarter-over-quarter from $44.3 million in Q3 2025, and down 4.73% on a YoY basis from $46.5 million in Q4 2024.
Arcellx (ACLX) Operating Leases (2022 - 2025) Analysis & Trends
Arcellx's Operating Leases history runs 4 years deep, the most recent figure standing at $44.3 million for Q4 2025.
- In Q4 2025, Operating Leases fell 4.73% year-over-year to $44.3 million; the TTM figure through Dec 2025 stood at $44.3 million (down 4.73% YoY), while the FY2025 annual figure was $44.3 million, down 4.73% from the prior year.
- Operating Leases was $44.3 million for Q4 2025 at Arcellx, roughly flat from $44.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $50.8 million in Q4 2023 to a low of $4.5 million in Q1 2022.
- Historically, Operating Leases has averaged $39.5 million across 4 years, with a median of $44.7 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Operating Leases surged 614.63% in 2023, then decreased 8.46% in 2024.
- A 4-year view of Operating Leases shows it stood at $31.3 million in 2022, then soared by 62.44% to $50.8 million in 2023, then retreated by 8.46% to $46.5 million in 2024, then dropped by 4.73% to $44.3 million in 2025.
- The last three Operating Leases figures came in at $44.3 million (Q4 2025), $44.3 million (Q3 2025), and $45.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.34 Mn |
| Sep 30, 2025 | 44.32 Mn |
| Jun 30, 2025 | 45.10 Mn |
| Mar 31, 2025 | 45.83 Mn |
| Dec 31, 2024 | 46.54 Mn |
| Sep 30, 2024 | 47.21 Mn |
| Jun 30, 2024 | 47.87 Mn |
| Mar 31, 2024 | 47.69 Mn |
| Dec 31, 2023 | 50.84 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 40.64 Mn |
| Mar 31, 2023 | 31.99 Mn |
| Dec 31, 2022 | 31.30 Mn |
| Sep 30, 2022 | 29.21 Mn |
| Jun 30, 2022 | 27.20 Mn |
| Mar 31, 2022 | 4.48 Mn |